Angio Suites - Market Insights, Competitive Landscape, and Market Forecast - 2030

Angio Suites Market By Type (Single-Plane And Bi-Plane), By Application (Angiography, Angioplasty, Stenting, Bypass Surgery, Others), and by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to upsurge in the cases of heart and circulatory disorders, increase in the cases of diabetes, along with rising geriatric population and constant technological advancements in product design.

The Global Angio Suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030. The Angio Suites market is slated to witness increasing revenue owing to factors such as a rise in the cases of heart and circulatory disorders, a rise in the number of diabetic patients globally coupled with the rising geriatric population, along with latest technological advancements to further enhance product safety and precision is expected to result in appreciable revenue growth in the Angio Suites market during the forecast period (2024-2030).

Angio Suites Market Dynamics:

One of the noteworthy drivers of the Angio suites market is the rise in the prevalence of heart and cardiovascular disorders such as coronary artery disease, heart attacks, stroke, etc. For instance, according to the Center for Disease Control and Prevention (2023), 18.2 million people aged 20 years and above in the United States had Coronary Artery Disease, in the year 2023. According to a study by the Global Burden of Cardiovascular Diseases (2019), the prevalence of heart and cardiovascular diseases across the world have almost doubled from 271 million in 1990 to 523 million in the year 2019. According to the same source, Ischemic Heart Disease and stroke are the major risk factors for disability and deaths in all high-income countries. For example, as per the data from American Heart Association (2019), over 41% of the U.S. population is likely to suffer from cardiovascular diseases by 2030. These numbers are further said to increase. For example, according to the reports from Pan American Health Organization (2023), there were 40.8 million disability-adjusted life years (DALYs), 4.5 million years lived with disability (YLDs), and 36.4 million years of lost life (YLLs) in the year 2019.

With these staggering numbers of cardiovascular disorders, factors such as diabetes and old age are also responsible for contributing to heart risks. For instance, according to the International Diabetes Federation Report (2023), there were more than 535 million people inflicted with diabetes in the year 2023, and the number of affected people is estimated to reach 780-783 million by the year 2045. The aforementioned source also stated that the rising incidences of obesity and a sedentary lifestyle are likely to increase the chances of diseases like atherosclerosis.

Thus, the rising prevalence of heart diseases and diabetes along with the growing geriatric population is expected to drive the demand for angio suites, eventually leading the global angio suites market growth during the forecast period (2024-2030).

Another prominent factor responsible for the growth of the Angio Suites market is the constant technological developments taking place in the Angio suites market for product design, and for increasing its safety and precision. For instance, in October 2022, Yashoda Hospitals, located in Secunderabad, India launched a 'Bi-Plane Neuro Angio Procedure Suite' with DTAS (Direct to Angio Suite) technology used for providing quick and highly advanced treatment in cases of brain stroke and neurological emergencies such as heart attacks. In another instance, in May 2022, Philips announced FDA 510(k) clearance for its new MR 7700 3.0T MR system, giving high performance and precision for both research and advanced clinical diagnostics.

However, the lack of healthcare infrastructure in low-income countries and the dearth of skilled workforce in terms of surgeons and cardiologists in the medical industry may act as restraining factors for the Angio Suites market.

The Angio Suites market reported a setback for a short time owing to the implementation of lockdown as necessary measures to break the chain of the COVID-19 infection transmission. The COVID-19 pandemic resulted in the massive reorganization of healthcare services and carrying out medical procedures. Many countries segregated medical procedures based on the need for urgent medical care to streamline the workflow during the COVID-19 crisis and saw various medical procedures considered elective being suspended. For instance, according to an article published by the Health design Organization (2023), to avoid contamination, the patients were isolated and treated in separate angio suites equipped with ventilation systems. Procedures involving life-threatening conditions like thrombectomy for stroke, endovascular aortic aneurysm repair for aortic ruptures, non-deferrable oncologic treatments, and organ-saving procedures were performed in most hospitals in acute cases of emergency, during the pandemic. Thus, due to the use of angio suites and surgical procedures only in cases of utmost need, the angio suites market observed a stagnant phase during the Covid-19 pandemic. However, with the resumption of activities across industries including the healthcare sector, it has been uplifting the angio suites market with constant patient diagnosis and surgical treatments, during the forecast period from 2024-2030.

Angio Suites Market Segment Analysis:

Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, Others), Geography (North-America, Europe, Asia-Pacific, Rest of the World).

Based on the Application segment of the Angio Suites market, the stenting category is projected to register significant growth in revenue in the Angio Suites market during the forecast period (2024-2030). This can be ascribed to an increase in stenting procedures around the world, required in acute cases of stroke. Owing to the rising prevalence of stroke cases globally, leading to serious consequences like disability and death, this segment of the Angio Suites Market is expected to generate considerable revenue during the forecast period. As per the reports from World Health Organization (2023), the prevalent cases of stroke were 15 million around the world, where 5 million of them were left disabled for a lifetime. In another example, according to the American Heart Association (2023), the prevalence of stroke in the United States in the year 2020 was 89.1 million, whereas that of ischemic stroke was 68.2 million and that of intracerebral hemorrhage was 18.9 million. The Global Stroke Fact Sheet (2023) of the World Stroke Organization (WSO) also reveals that the rates of people having a stroke has substantially risen, with a whopping 70% increase in the global stroke rate in 2019, as compared to 1990.

Further, considering the growing demand for this segment of the application, various new products are being launched in the market with technological advancements, for the diagnosis and treatment of strokes.

For instance, In June 2022, Siemens Healthineers, a part of Siemens, launched the Angiography System Artis Icono, for various applications like stenting, stroke diagnosis and treatment and others. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.

In September 2019, another example of one of the latest developments involving two big players in the angio suites industry is that of Onvision Needle Tip Tracking Technology, manufactured from the collaboration of Philips and B. Braun for the accurate diagnosis and treatment of stroke. In August 2020, this Onvision Needle Tip Tracking Technology received FDA clearance from the U.S Food and Drug Administration.

Therefore, as per the above-mentioned factors such as the increasing cases of stroke along with technological developments from key players, this segment of the Angio suites market is expected to grow significantly during the given forecast period (2024-2030).

North America is expected to dominate the overall Angio Suites Market:

Among all the regions, North America is expected to lead in revenue generation in the global Angio Suites market. This can be ascribed to the massive rise in the cases of heart disorders and diabetes, ultimately requiring diagnostic procedures and treatments like angiography, angioplasty, stenting, bypass surgery and others in the North American region. The most common types of heart diseases in North America, and specifically in the U.S are Coronary Artery disease and stroke. According to the Centre for Disease Prevention and Control (2023), in the year 2019, about 18.2 million people above the age of 20 had Coronary Artery Disease which was the biggest contributor to deaths in the U.S., responsible for 3,60,900 deaths in the same year.

Along with Coronary heart disease, the cases of stroke are also on the rise in the United States. For example, according to the Centre for Disease Control and Prevention (2023) of Stroke Statistics, every 40 seconds a person had a stroke in the United States. The same source also stated that on average 795,000 people have a stroke every year, with 610,000 stroke cases being the first.

Thus, owing to such a high prevalence of heart disorders and the presence of a large patient pool in the United States, many angio suites are getting FDA approvals for their commercial use in markets. For instance, in March 2022, Philips received 510(k) market clearance from the U.S. Food & Drug Administration (FDA) for its angio suite Philips Capsule Surveillance solution, paving the way for widespread deployment across healthcare systems in the USA. The angio suite is capable of utilizing streaming data from virtually any connected medical device and helps in the analysis to generate actionable insights and alerts.

Along with the prevalence of heart disorders, diabetes has also been one of the major factors for the growth of the Angio Suites market in North America. According to the Centre for Disease Control and Prevention, National Diabetes Statistics (2023), more than 130 million people were living with diabetes or pre-diabetes in the year 2019. According to the same source, more than 1.4 million new cases of diabetes were diagnosed in people aged 18 years and above, in the year 2019.

Not only is the U.S. in North America, but Canada also one of the most affected countries by heart diseases like stroke. According to the American Health Association (2023), Canada stands the second most to be affected by stroke globally in the year 2023. Along with this, Canada also stands forward in the number of hospitalizations related to heart conditions.

For example, according to the Heart and Stroke Foundation of Canada (2023), 2.6 million hospitalizations happened in Canada in the year 2019, associated with some heart conditions such as vascular cognitive impairment or stroke. The source also mentioned that out of the total hospitalizations for heart disorders, 50% of hospitalizations were for structural heart disease, 35% for vascular cognitive impairment related conditions, and the rest 25% for heart failures. Owing to such a high prevalence of heart disorders and the rising number of hospitalizations requiring angio suites in the country, big companies are collaborating with small-scale industries to expand their range of treatment and expertise.

For instance, in June 2022, Canon Medical Systems decided to collaborate with The Harley Street Healthcare Group Canada to launch a group of innovative diagnostic centers across Ontario. The diagnostic center is said to possess a highly equipped Angiography suite with the latest X-ray generators, Molecular Imaging, Ultrasound, and Healthcare Informatics.

In another instance, in March 2019, Conavi Medical Inc. Canada received the Health Canada Medical Device License for its Novasight Hybrid System, which is an Angio Suite enabling simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) having the potential to improve clinical outcomes during angioplasty and stenting.

Therefore, the presence of a large patient population base with heart disorders, coupled with a rise in technological advancements and product launches for increasing the safety and precision of angio suites is expected to bolster the growth of the Angio suites market in the North American region during the forecast period.

Angio Suites Market Key Players:

Some of the key market players operating in the Angio Suites market include Siemens, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems Inc., General Electric, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B. Braun, and others.

Recent Developmental Activities in Angio Suites Market:

In June 2022, Siemens Healthineers, a part of Siemens, launched the Angiography System Artis Icono, for precise tumor embolization. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.

In December 2022, GE Healthcare, an auxiliary company of well-known Massachusetts, United states-based company "General Electric" announced the successful acquisition of Boston, United States-based imaging company "BK Medical."

In December 2020, GE Healthcare launched the Allia IGS 7 angiography system which is a new version of its robotic-driven angiography system for image-guided therapy, at the Radiological Society of North America (RSNA) virtual meeting 2020.

Key Takeaways from the Angio Suites Market Report Study

• Market size analysis for current Angio Suites market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Angio Suites market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years.
• Key companies dominating the global Angio Suites market.
• Various opportunities available for the other competitor in the Angio Suites market space.
• What are the top performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Angio Suites market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Angio Suites market growth in the coming future?

Target Audience who can be benefited from this Angio Suites Market Report Study

• Angio Suite providers
• Research organizations and consulting companies
• Angio Suites -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Angio Suites and equipments
• Various end users who want to know more about the Angio Suites market and latest technological developments in the Angio Suites market.

Frequently Asked Questions for Angio Suites Market:

1. What are Angio Suites?

An angio suite is an examination room where complex surgical procedures like angiography, stenting, bypass surgery, etc. are performed with high precision. It helps in the detection and observation of damaged blood vessels present in different organs, helping in the diagnosis and treatment of conditions like aneurysms, vascular stenosis, coronary atherosclerosis, etc.

2. What is the market for Global Angio Suites?

The Global Angio Suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030

3. What are the drivers for the Global Angio Suites market?

The Angio Suites market is expected to grow significantly owing to factors such as a rise in the prevalence of heart and circulatory disorders requiring procedures such as angioplasty, angiography, stents, bypass, myelography, etc. along with the rising geriatric population globally. The rapidly growing diabetic population coupled with technological advancements in the Angio Suites market for delivering quality treatment with better precision is further expected to result in appreciable revenue growth in the Angio Suites market during the given forecast period (2024-2030).

4. Who are the key players operating in Global Angio Suites Market?

Some of the key market players operating in the Angio Suites market include Siemens, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems Inc., General Electric, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B. Braun, and others.

5. Which region has the highest share in the Angio Suites market?

North America is expected to dominate the overall Angio Suites market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a large patient population with heart diseases and diabetes, which can also be ascribed to the reason for the rising geriatric population in the North American region. In addition, it is a highly potent market in terms of technological developments and launches along with the presence of key market players among other factors in the region.